A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.

Autores de IIS La Fe

• Pau Montesinos Fernández

  Autor

• David Martínez Cuadrón

  Autor

• José Bueno Lledó

  Autor

• Miguel Ángel Sanz Alonso

  Autor

Participantes ajenos a IIS La Fe

• Valcárcel D
• Sánchez-Ortega I
• Brunet S
• Esteve J
• Ribera JM
• Tormo M
• Duarte R
• Llorente A
• Torres JP
• Guardia R
• Sierra AJ
• CETLAM Group

Grupos

• Hematología y Hemoterapia

Abstract

A prognostic index to predict induction death in adult patients receiving induction chemotherapy for de novo acute myeloid leukemia (AML) was developed.